17 related articles for article (PubMed ID: 27245274)
1. A validated LC-MS/MS method for determination of neuro-pharmacokinetic behavior of niraparib in brain tumor patients.
Knight W; Margaryan T; Sanai N; Tovmasyan A
J Pharm Biomed Anal; 2024 Aug; 245():116150. PubMed ID: 38657366
[TBL] [Abstract][Full Text] [Related]
2. Dr Bates and the NHS/GDC?
Ward P
Br Dent J; 2024 Feb; 236(3):145. PubMed ID: 38332055
[No Abstract] [Full Text] [Related]
3. Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets.
Sofianidi A; Dumbrava EE; Syrigos KN; Nasrazadani A
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539474
[TBL] [Abstract][Full Text] [Related]
4. A supported liquid extraction-LC-MS/MS method for determination of GDC-0980 (Apitolisib), a dual small-molecule inhibitor of class 1A phosphoinositide 3-kinase and mammalian target of rapamycin, in human plasma.
Ding X; Li F; McKnight J; Schmidt C; Strooisma K; Shimizu H; Faber K; Ware JA; Dean B
J Pharm Biomed Anal; 2014 Nov; 100():150-156. PubMed ID: 25165011
[TBL] [Abstract][Full Text] [Related]
5. A solid phase extraction-liquid chromatographic-tandem mass spectrometry method for determination of concentrations of GDC-0941, a small molecule class I phosphatidylinositide 3-kinase inhibitor, to support clinical development.
Ding X; Morrison G; Dean B; Hop CE; Tobler L; Percey S; Meng M; Reuschel S; West DA; Holden S; Ware JA
J Pharm Biomed Anal; 2012 Mar; 61():1-7. PubMed ID: 22169467
[TBL] [Abstract][Full Text] [Related]
6. Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS.
Ding X; Faber K; Shi Y; McKnight J; Dorshorst D; Ware JA; Dean B
J Pharm Biomed Anal; 2016 Jul; 126():117-23. PubMed ID: 27187764
[TBL] [Abstract][Full Text] [Related]
7. Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry.
Ding X; Chou B; Graham RA; Cheeti S; Percey S; Matassa LC; Reuschel SA; Meng M; Liu S; Voelker T; Lum BL; Rudewicz PJ; Hop CE
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):785-90. PubMed ID: 20172765
[TBL] [Abstract][Full Text] [Related]
8. Validation and application of a liquid chromatography-tandem mass spectrometric method for the determination of GDC-0879 and its metabolite in dog plasma using solid phase extraction.
Chou B; Adler RS; Meng M; Percey S; Dean B; Hop CE; Shin YG
J Pharm Biomed Anal; 2012 Nov; 70():354-61. PubMed ID: 22717139
[TBL] [Abstract][Full Text] [Related]
9. A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasma.
Ding X; Chen Y; Sahasranaman S; Shi Y; McKnight J; Dean B
Biomed Chromatogr; 2016 Dec; 30(12):1984-1991. PubMed ID: 27245274
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
